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Abstract
The purpose of the study was to assess the impact of an educational intervention on prostate 
cancer screening behavior and knowledge. Participants were 104 African American men, 45 years 
and older, who had not been screened for prostate cancer with a prostate-specific antigen and/or 
digital rectal exam within the past year. All participants received an intervention delivered by 
trained lay community educators using a prostate cancer educational brochure developed in 
collaboration with the community, with structured interviews preintervention and 3 months 
postintervention. The main study outcomes included prostate-specific antigen screening rates 
during the 3-month interval and knowledge, barriers to screenings, and decisional conflict around 
screening. Compared with the 46 men who did not get screened, the 58 participants who got 
screened were more likely to have greater than a high school education, annual household incomes 
≥$25,000, and a family history of non-prostate cancer (p < .05). Average knowledge scores 
increased, and barriers to screening scores decreased, from preintervention to postintervention 
only for participants who had been screened (p < .05). The results of this study demonstrate the 
feasibility and efficacy of an academic institution collaborating with the African American 
community to develop a successful prostate cancer educational intervention, an approach that can 
be expanded to other cancers and other chronic diseases.
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Prostate cancer (PCa) is the second leading cause of cancer-related death for men in the 
United States (American Cancer Society, 2007; Jemal et al., 2008). African American men 
bear a disproportionate burden for PCa incidence and mortality, having the highest 
incidence, poorest survival, and a twofold higher mortality when compared with other racial 
and ethnic groups in the United States (American Cancer Society, 2007; Austin et al., 1990; 
Merrill & Lyon, 2000; Ries et al., 2008).
The causes for these disparities in African Americans are complex and may include an 
increased genetic vulnerability for PCa, unequal access to adequate treatments, delay in 
diagnosis, and increased susceptibility to more aggressive forms of PCa (Berger, Satagopan, 
Lee, Taneja, & Osman, 2006; Merrill & Brawley, 1997). Addressing these disparities in 
African American men is complicated by the fact that the benefit of PCa screening has been 
a controversial issue. For instance, there is inconclusive evidence that early detection of PCa 
through screening actually improves disease-specific mortality (Coley, Barry, Fleming, 
Fahs, & Mulley, 1997; Coley, Barry, Fleming, & Mulley, 1997; Gerald et al., 2009; 
Schroder et al., 2009). In addition, there is an ongoing debate whether the potential benefits 
of screening outweigh the potential risks associated with treatment. These risks include 
impotence, incontinence, and anxiety of a cancer diagnosis. Also, there is the question of 
whether or not life expectancy is improved as a result of screening and subsequent 
treatment. Some prostate cancers are very slow growing and would not threaten the life of 
the patient if not treated.
In light of this information, most medical professionals and cancer-related organizations 
have promoted informed decision making such that patients are informed about the risks and 
benefits of PCa screening. A 2007 review of current cancer guidelines, practices, and 
prospects emphasized informed decision making and shared decision making so that the 
potential benefits, limitations, and harm associated with testing for and treating PCa are fully 
discussed (Krist, Woolf, Johnson, & Kerns, 2007; Volk, Spann, Cass, & Hawley, 2003; 
Watson et al., 2006). Informed decision making is also the cornerstone of new 2010 
recommendations regarding PCa screening from the American Cancer Society (Wolf et al., 
2010).
Several factors have been associated with an increase in PCa screening, including having a 
positive family history of prostate and other cancers, being older, being employed, having a 
higher income, having an intention to getting screened, perceiving one’s health as good or 
excellent, and having a usual source of health care (Ford, Vernon, Havstad, Thomas, & 
Davis, 2006; Niven, Herman, Pweinrich, & Weinrich, 2001). In addition, family and friends, 
having a trusting relationship with a health care provider, and recruitment strategies that are 
based in the community or where African Americans work and live have been shown to play 
an important role in the PCa screening decision-making process (Jones, Steeves, & 
Williams, 2009, 2010).
Research in the area of PCa educational interventions offers promise to improve knowledge 
about the disease and reducing decisional conflicts with regard to the risks and benefits 
associated with screening. However, existing studies have revealed mixed results regarding 
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PCa screening outcomes (Davison, Kirk, Degner, & Hassard, 1999; Frosch, Kaplan, & 
Felitti, 2003; Partin et al., 2004; Schapira & VanRuiswyk, 2000; Volk et al., 2003). 
Interventions in these areas have used a variety of formats including videotapes, Internet 
interventions, pamphlets, and face-to-face education. Despite this increase in educational 
materials for PCa, there has been little effort to develop materials specifically for African 
American men. Given the state of disparities in incidence, mortality, and survival rates, it is 
critically important to develop culturally tailored educational interventions for African 
American men.
The present study examines the efficacy of an educational intervention in improving 
informed decision making with regard to PCa screening, screening rates, and PCa 
knowledge in primarily low-income African American men. The development of this 
intervention was driven by a community-academic linkage, using community-based 
participatory research (CBPR) methodology. A community advisory board (CAB) 
consisting of community residents and representatives was used in developing the content 
and language of the intervention brochure.
Method
Participants were recruited face-to-face from the lobby area of Matthew Walker 
Comprehensive Health Center (MWCHC) and at community events such as health fairs. 
MWCHC is a federally funded (Health Resources and Services Administration) community 
health center that serves primarily low-income communities. MWCHC serves more than 
18,000 patients a year and the majority of their patient population is African American, 
uninsured, and has an annual household income of ≤$15,000. In addition, participants were 
recruited through flyers posted at community businesses and community centers. These 
flyers provided a brief description of the study, eligibility criteria for participating, and a 
number to call for those interested in participating. The recruitment was conducted by lay 
community educators who were trained to screen for study eligibility. These eligibility 
criteria included being self-identified African American, being male, not having been 
screened for PCa in the past year with a prostate specific antigen (PSA) test or digital rectal 
exam (DRE), being 45 years or older, and being a resident of Davidson County/Nashville, 
Tennessee, for at least 6 months. The rationale for selecting men over 45 was that 
organizations such as the American Cancer Society recommend that men begin at age 50 to 
be tested annually by PSA and DRE, whereas those at increased risk, such as African 
Americans and men with a family history of the disease, can start at 45 (U.S. Preventive 
Services Task Force, 2002). The study protocol was approved by the Meharry Medical 
College Institutional Review Board.
A series of workshops were conducted by the study investigators to train the lay community 
educators in recruiting eligible participants, obtaining written informed consent, 
administering the assessments, and delivering the intervention. Lay community educators 
were recruited from the focus groups that were conducted as part of the intervention 
development (see section below). Three were recruited and all were African American men. 
The trained lay community educators obtained informed consent from participants and 
conducted the preintervention assessments. The assessment information collected from 
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participants included demographic characteristics (age, race, income, education, marital 
status, employment status), health insurance coverage, height and weight, information about 
barriers to PCa screening, and PCa screening history. The intervention involved educating 
participants about PCa using an educational brochure, which was developed in collaboration 
with the target community. The study lay community educators discussed the information in 
the brochure with participants and used active learning techniques such as having 
participants paraphrase what was discussed.
Intervention Development
CBPR principles provided the guidelines for intervention development. CBPR is a research 
approach that mandates a partnership between traditionally trained experts and members of a 
community, with all parties interested in addressing a common research problem. This 
approach requires for the community to be a full research partner, participating in the 
planning, development, implementation, evaluation, and dissemination of the research. 
CBPR is characterized by substantial community input in the development and 
implementation of a research proposal. The nine principles of CBPR encompass the 
following: (1) acknowledge the community, (2) foster colearning and capacity building for 
all, (3) build on strengths and resources within the community, (4) integrate and achieve a 
balance of all partners, (5) facilitate collaborative, equitable partnership in all phases of the 
research, (6) focus on the local relevance and determinants of health, (7) involve a cyclical 
process, (8) disseminate findings and knowledge gained to all partners and to involve all 
partners in the dissemination process, and (9) involve a long-term process and commitment 
(Israel et al., 2003).
Three focus groups were conducted to develop a catalog of barriers to PCa screening. The 
first focus group consisted of self-identified African American men above the age of 40 
years who had been screened for PCa in the past year. The second focus group consisted of 
African American men 40 years and older and who had not been screened for PCa in the 
past year. The rationale for these groups was to gain understanding of barriers to PCa 
screening from the perspective of those who had been screened versus those who had not. 
The final focus group consisted of family members and significant others of participants in 
the first two focus groups. The rationale for this focus group was to gain insight and 
understanding of the barriers that family members identify for PCa screening. All the focus 
groups consisted of 8 to 10 participants.
The focus groups were conducted at MWCHC and were moderated by a pastor. This 
moderator was selected because he was a member of the target community, and he had 
experience moderating focus groups in past community-based projects. The moderator was 
provided with a list of “probing questions” to facilitate the discussions. Each participant 
provided informed consent prior to his participation, including an agreement (or refusal) to 
be video- and audio-taped during the sessions. Participants were also asked to provide 
permission to be contacted if they were selected to be on the CAB.
The CAB, consisting of five members each from the three focus groups, developed an 
educational brochure that would serve as the intervention to be administered by the lay 
community educators. CAB members provided informed consent prior to their participation 
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and received a light meal and a $45 cash incentive for each CAB session. All CAB sessions 
were moderated by an African American pastor.
Three CAB sessions were used to develop the educational brochure. In Session 1, CAB 
members were provided a list of barriers generated in the focus groups, and the moderator 
engaged in a discussion to generate solutions to these barriers. “Prostate Cancer Screening: 
A Decision Guide for African Americans” from the CDC website (http://www.cdc.gov) was 
provided as homework reading for the next session. In Session 2, CAB members generated 
the content of the brochure. The content included a description of the prostate, screening 
options, reliability of these screening tests, impact of PCa on the African American 
population, and solutions to various barriers to screening. In Session 3, CAB members were 
presented with a draft of a brochure. They focused on modifying the brochure language to 
make it easy to read and understand. Focus group participants and members of the CAB 
were excluded from the study.
Intervention: Data Collection, Coding, and Analysis
Structured interviews with the study participants were conducted by lay educators at entry 
into the study and 3 months postintervention. Knowledge scores for PCa were measured by 
the Actual Knowledge of Prostate Cancer subscale of the Prostate Knowledge Questionnaire 
developed by Agho and Lewis (2001). This subscale has 21 items and was designed to 
measure the extent to which a person can recognize general factual information about PCa. 
The scale contains items such as “African American men are less likely to develop this type 
of cancer, True or False.” The advantage of this subscale is that it was designed to be used 
with African American men and has a Cronbach α of .87, which indicates good reliability. 
Responses on this subscale were summed to provide an overall prostate cancer knowledge 
score. The maximum knowledge score was 21, with the higher scores representing greater 
PCa knowledge.
Decisional conflict regarding PCa screening was measured by an 8-item version of the 
Decisional Conflict Scale adapted by Taylor et al. (2006). This adapted scale has a binary 
response format (“No = 1,” “Yes = 0”) with lower summed scores indicating greater level of 
informed decision making with respect to engaging in screening for PCa. The maximum 
score on this scale is 8 and the minimum is 0. This scale was designed for use with African 
Americans and has a Cronbach α of .76, which indicates adequate reliability.
Barriers to PCa screening were summed to create a total barrier score. Participants were 
presented with a list of 11 barriers to screening and were instructed to indicate all the 
barriers that applied to them. A score of “1” was given to any barrier that was reported. 
Scores on these 11 barriers were summed. The maximum total barrier score was 11, with the 
higher scores indicating that a participant perceived a greater number of barriers to screening 
for PCa.
The primary outcome of interest was screening for prostate cancer with the PSA test. The 
rationale for selecting this test is that MWCHC, which is the primary screening provider for 
this study, uses only PSA as part of their PCa screening protocol. Chi-square tests and the 
analysis of variance were used to examine the difference between demographic and lifestyle 
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characteristics by screening status. A multivariate analysis of covariance (MANCOVA) was 
used to evaluate the associations between pre- and postintervention scores in PCa 
knowledge, barriers to screening, and screening status. To adjust for potential confounding, 
key demographic variables were controlled. A multiple linear regression model was 
conducted to examine the predictive function of demographic and lifestyle variables for the 
decisional conflict scores at postintervention. All data analyses were conducted using 
Version 9.2 of the SAS System for Windows (SAS Institute Inc., Cary, NC) and based on 
two-sided probability.
Results
Demographic and Lifestyle Characteristics
The intervention, as well as pre- and postintervention interviews, were delivered to 104 
African American men, 58 (56%) of whom underwent PSA screening in the interval and 46 
of whom did not. Demographic and lifestyle characteristics of the study participants are 
presented in Table 1. Differences between the screened and unscreened groups were not 
large, except that participants who reported getting screened were more likely to report 
having had greater than a high school education compared with those that did not get 
screened (48% vs. 13%), have an annual household income equal to or greater than $15,000 
(61% vs. 38%), and were more likely to report having a family history of any other cancer 
except PCa (67% vs. 41%; all p < .05).
Relationship Between Screening Status and PCa Knowledge
The MANCOVA conducted to investigate the relationships between prostate cancer pre- and 
postintervention knowledge scores and screening status revealed a significant interaction 
between screening status and knowledge scores (p = .04), as shown in Figure 1. The average 
knowledge scores increased from preintervention to postintervention for participants who 
had gotten screened, but not among participants who did not get screened.
Barriers to Prostate Cancer Screening
Barriers to PCa screening by screening status and time are illustrated in Table 2. 
Preintervention, there were no significant differences between those who subsequently got 
versus did not get screened in any of the nine barriers listed. Postintervention, however, the 
two groups differed in seven of the nine barriers. The percentages of the screened reporting 
barriers tended to decline from pre- to postintervention, whereas the percentages of the 
unscreened tended to rise. The largest barrier to PCa screening reported by participants in 
both groups was not having health insurance, but this percentage rose from 39% to 65% for 
the unscreened pre- to postintervention, while declining from 46% to 33% for the screened. 
In the MANCOVA conducted to investigate the relationships of total barrier scores and 
screening status between pre- and postintervention, there was a significant interaction 
between screening status and time (p = .003), which is visualized in Figure 2. The total 
barrier scores decreased at postintervention only for participants who had been screened, 
while increasing for participants who did not get screened.
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Decisional Conflict for Prostate Cancer Screening
A multiple linear regression model was used to investigate the predictive function of 
demographic and lifestyle variables for decisional conflict for PCa screening at 
postintervention. There were no significant demographic or lifestyle predictors of decisional 
conflict. Furthermore, screening status was also a nonsignificant predictor of decisional 
conflict for PCa screening.
Discussion
In the 3 months following the community-derived intervention, 56% of the study 
participants reported getting a PSA test. This is higher than the 48% annual PCa screening 
rate in the State of Tennessee for 2008 (U.S. Department of Health and Human Services, 
n.d.). This result speaks to the effectiveness of the intervention in getting a majority of 
participants who had not gotten screened in the past 2 years to engage in screening. In fact, 
this intervention led to a higher screening rate than that found among men in the State of 
Tennessee.
The relationship between PCa knowledge and actual screening behavior is not well 
established. Studies have revealed mixed results, with some indicating that an increase in 
PCa knowledge is associated with an increase in PCa screening behavior, whereas others 
have found that screening behavior is either unaffected or actually decreases (Davison et al., 
1999; Frosch et al., 2003; Partin et al., 2004; Schapira & VanRuiswyk, 2000; Volk et al., 
2003). In this study, we found that only participants who had been screened by the end of 
the follow-up reported an increase in PCa knowledge. At present, it is unclear if these 
findings represent cultural differences, since a majority of the previous studies on PCa have 
been conducted with Caucasian populations. The intervention attempted to provide balanced 
information about the benefits, risks, and accuracy of current PCa screening tests. It may be 
that some participants recognized from this information that there is no viable alternative to 
current screening practices and decided to address their prostate health with the available 
screening options. Furthermore, the intervention contained information about barriers to 
screening and strategies to overcome these barriers. This information may have eased their 
perceptions about difficulties associated with screening. Indeed, among those who had the 
PSA testing done, the percentage reporting barriers declined in the postintervention period.
In this study, there were no significant demographic or lifestyle predictors of decisional 
conflict for PCa screening. Compared with men who did not get screened, those who 
screened did not report less decisional conflict about screening. Also, improving PCa 
knowledge apparently does not seem to influence decisional conflict. These results suggest 
that decisional conflict about PCa screening may be affected by other factors such as social 
influences (family and friends) or existing beliefs and perceptions about cancer screening 
such as fear of finding out about having cancer.
Level of education, income, and having been screened for PCa in the past were the only 
sociodemographic or lifestyle variables that we found had a significant relationship with 
screening status. Unlike prior research, this study did not find that being married, being 
older, having a family history of PCa, and having health insurance were significantly 
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associated with being screened for PCa (Chiu, Anderson, & Corbin, 2005; Ford et al., 2006; 
Nivens et al., 2001; Spencer et al., 2006). However, our participants at baseline were a 
relatively similar with regard to not having been screened in the past year, tending to lessen 
differences often found between screening and nonscreening groups in cross-sectional 
studies.
An interesting finding of this study was the relationship between screening status and 
perceptions about barriers to screening. At preintervention, participants who were screened 
and those that did not get screened had very similar perceptions about barriers to getting 
screened. At postintervention, there were several social determinants of health that 
influenced screening behavior. For example, compared with participants who did not get 
screened, those who screened at postintervention were less likely to report not having health 
insurance, cost of cancer screenings, difficulty getting time off work, and transportation 
issues as barriers to screening. Perceptions about screening also played a role at 
postintervention. For example, compared with participants who did not get screened, those 
who screened at postintervention were less likely to report not having enough information 
about screenings and not knowing where to get screened.
The impact of social determinants of health and perceptions about screening at 
postintervention were reflected in the total barrier scores that decreased only for participants 
who had been screened. Barrier scores for participants who did not get screened actually 
increased at postintervention compared with their preintervention scores. These results 
suggest that engaging in screening activity may lead to a positive reassessment of the 
obstacles involved in getting screening. It is unclear why the total barrier scores increased 
among participants who did not get screened. One possible explanation is that this group 
discovered that the obstacles to screening were greater than they initially perceived. Another 
explanation is that participants in this group reported a greater number of barriers at 
postintervention as a way to justify to themselves and/or others their failure to get screened.
Strengths and Limitations
This study had some notable strengths including that the self-reported PCa screening was 
confirmed using the MWCHC clinic database. All the participants in this study who were 
screened reported using this medical facility for their screening. In addition, this study 
provided information about barriers to PCa screening for primarily low-income African 
American men, a group at high risk for PCa incidence and mortality. Limitations of this 
study include that the data were primarily cross-sectional in nature, hence causation cannot 
be inferred. In addition, a majority of the variables were based on self-report and 
respondents may be unwilling to reveal or may not have accurate knowledge about their 
health status. In addition, this study had a small and convenient sample, both of which may 
affect the generalizability of the results.
Conclusion
The results of this study demonstrate the feasibility and efficacy of collaborating with the 
target community to develop a PCa educational intervention that increased knowledge and 
Patel et al. Page 8













screening rates. This methodology of using a community–academic collaboration to develop 
interventions can be expanded to other cancers and other chronic diseases.
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Interaction between screening status and time for knowledge scores
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Interaction between screening status and time for barriers scores
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Table 1
Demographic and Lifestyle Characteristics of the Participants at Entry Into the Study
Variables
Eligible Participants,
N = 104 (%)
Screened,
N = 58 (%)
Not Screened,
N = 46 (%) p Value
Age at interview (years) 51.7 ± 6.6 51.4 ± 6.2 52.2 ± 7.1 .557
Education
 Less than or equal to high school 69 (68%) 29 (52%) 40 (87%) <.001
 More than high school 33 (32%) 27 (48%) 6 (13%)
Marital status
 Married/living with a partner 29 (29%) 17 (31%) 12 (27%) .644
 Divorced/widowed/separated 41 (41%) 24 (44%) 17 (39%)
 Never married 29 (29%) 14 (25%) 15 (34%)
Employment status
 Employed 49 (48%) 30 (54%) 19 (41%) .217
 Unemployed 53 (52%) 26 (46%) 27 (59%)
Annual household income
 <$15,000 50 (50%) 22 (39%) 28 (62%) .022
 ≥$15,000 51 (50%) 34 (61%) 17 (38%)
Self-rated health
 Excellent/very good/good 73 (72%) 38 (68%) 35 (76%) .359
 Fair/poor 29 (28%) 18 (32%) 11 (24%)
Health insurance
 Yes 42 (41%) 26 (46%) 16 (35%) .266
 No 61 (59%) 31 (54%) 30 (65%)
Having personal doctor or health care provider
 Yes 61 (60%) 35 (60%) 26 (59%) .898
 No 41 (40%) 23 (40%) 18 (41%)
How long since last routine checkup?
 Within past year 27 (28%) 19 (34%) 8 (19%) .103
 More than 1 year ago 71 (72%) 37 (66%) 34 (81%)
Have any of your relatives had prostate cancer?
 Yes 22 (21%) 14 (25%) 8 (17%) .377
 No 81 (79%) 43 (75%) 38 (83%)
Have any of your relatives had any other cancer, except prostate cancer?
 Yes 57 (55%) 38 (67%) 19 (41%) .010
 No 46 (45%) 19 (33%) 27 (59%)
Have you ever had a PSA test or digital rectal exam?
 Yes 27 (26%) 11 (19%) 16 (35%) .076
 No 76 (74%) 46 (81%) 30 (65%)
Note. PSA test = prostate-specific antigen test.
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Table 2




Screened p Value Screened
Not
Screened p Value
Fear of finding out I have cancer 25 (44%) 12 (27%) .073 10 (18%) 8 (18%) .967
Not having health insurance 26 (46%) 18 (39%) .508 19 (33%) 30 (65%) .001
Cost of cancer screenings 20 (35%) 18 (39%) .673 16 (28%) 22 (49%) .031
Pain and discomfort of screenings 19 (34%) 14 (31%) .764 16 (28%) 19 (42%) .120
Difficulty getting time off work 9 (16%) 5 (11%) .469 8 (14%) 16 (36%) .011
Trouble remembering schedule screenings 15 (26%) 13 (28%) .825 12 (21%) 25 (54%) <.001
Not having enough information about screenings 16 (28%) 11 (24%) .633 7 (12%) 23 (50%) <.001
Not knowing where to get screened 10 (18%) 10 (22%) .593 11 (19%) 20 (43%) .007
Transportation issues 11 (19%) 13 (28%) .285 9 (16%) 19 (42%) .003
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